Migrén: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• MMA Embolization for Refractory Chronic Migraine

  NCT06735833· Cerenovus, Part of DePuy Synthes Products, Inc.· Source

• Treatment for Migraine and Mood

  NCT05576467· Amanda Shallcross· Source

• Cocoa Extract for Migraine Trial

  NCT06808230· Brigham and Women's Hospital· Source

• Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)

  NCT07191145· Sunnybrook Health Sciences Centre· Source

• Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine

  NCT03832998· Amgen· Source

• A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

  NCT06602479· AbbVie· Source

• Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  NCT04649242· Pfizer· Source

• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  NCT04743141· Pfizer· Source

• Laser Acupuncture for Chronic Migraine: Clinical Response, Traditional Chinese Medicine Syndrome Patterns, and Brain Function

  NCT07891585· Taichung Veterans General Hospital· Source

• A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

  NCT06616194· Pfizer· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Mendelian Randomization Analysis 2
• Mass Spectrometry 1
• Magnetic Resonance Imaging 4
• Cohort Studies 4
• Genome-Wide Association Study 3

See which targets of this disease your abstract mentions, and go to the people working on them.